Uremic toxin precursor

“Uremic toxin precursor” refers collectively to metabolic intermediates—mainly phenolic and indolic compounds—produced by gut bacteria through the breakdown of aromatic amino acids like tryptophan and tyrosine. These compounds serve as substrates for further conversion into protein-bound uremic toxins such as p-cresyl sulfate and indoxyl sulfate. In chronic kidney disease, impaired renal clearance leads to accumulation of both the parent compounds and their toxic derivatives, contributing significantly to inflammation, cardiovascular morbidity/mortality, and progression of renal dysfunction. The term also encompasses certain bacterial species capable of generating these intermediates from dietary proteins within the colon.

Other names

Uremic solute precursorProtein-bound uremic toxin (PBUT) precursorGut-derived uremic toxin substrate

Drugs/interventions may act by altering gut microbiota composition to reduce production of these precursors. Adsorbents may bind downstream toxins derived from these precursors before systemic absorption.